Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Finished Goods (2016 - 2025)

Bio-Techne (TECH) has 15 years of Finished Goods data on record, last reported at $114.8 million in Q4 2025.

  • For Q4 2025, Finished Goods rose 4.26% year-over-year to $114.8 million; the TTM value through Dec 2025 reached $114.8 million, up 4.26%, while the annual FY2025 figure was $106.2 million, 0.11% changed from the prior year.
  • Finished Goods reached $114.8 million in Q4 2025 per TECH's latest filing, roughly flat from $114.9 million in the prior quarter.
  • Across five years, Finished Goods topped out at $114.9 million in Q3 2025 and bottomed at $66.9 million in Q2 2022.
  • Average Finished Goods over 5 years is $97.6 million, with a median of $105.2 million recorded in 2024.
  • Peak YoY movement for Finished Goods: dropped 0.25% in 2022, then skyrocketed 38.14% in 2023.
  • A 5-year view of Finished Goods shows it stood at $67.1 million in 2021, then increased by 20.03% to $80.5 million in 2022, then grew by 27.76% to $102.9 million in 2023, then grew by 7.04% to $110.2 million in 2024, then increased by 4.26% to $114.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Finished Goods were $114.8 million in Q4 2025, $114.9 million in Q3 2025, and $106.2 million in Q2 2025.